Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer. Journal of Cancer Research Updates, [S. l.], v. 15, n. 3, p. 186–196, 2026. DOI: 10.30683/1929-2279.2026.15.17. Disponível em: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/969. Acesso em: 16 jul. 2026.